4 results  1 of 1 

1 Efficacy and Safety Profile of TS-1 or TS-1/CDDP in Patients with Advanced Gastric Cancer
Taekyung Ha, Sung Joon Kwon
J Korean Gastric Cancer Assoc.2006;6(3):139-145.   Published online 2017 March 13     DOI: http://dx.doi.org/10.5230/jkgca.2006.6.3.139
   
2 Interstitial lung disease caused by TS-1: a case of long-term drug retention as a fatal adverse reaction
Joong-Min Park, In Gyu Hwang, Suk-Won Suh, Kyong-Choun Chi
J Korean Surg Soc.2011;81(6):414-418.   Published online 2011 November 25     DOI: http://dx.doi.org/10.4174/jkss.2011.81.6.414
   
3 Clinical outcomes of TS-1 chemotherapy for advanced and recurrent gastric cancer
Sung Ryol Lee, Hyung Ook Kim, Chang Hak Yoo
J Korean Surg Soc.2011;81(3):163-168.   Published online 2011 September 26     DOI: http://dx.doi.org/10.4174/jkss.2011.81.3.163
   
4 A Case of Soft Tissue Bleeding Due to a Possible Drug Interaction between Warfarin and TS-1
Jae-min Chun, Nam-Sook Park, Nam-Hwan Park, Gak-Won Yun, Young-Joon Yang, Hwan-Jung Yun, Deog-Yeon Jo, Samyong Kim
Korean J Hematol.2005;40(4):271-273.   Published online 2005 December 21     DOI: http://dx.doi.org/10.5045/kjh.2005.40.4.271
   

 1 of 1